创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Immunoco-culture killing model features introduction

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-02-05 14:16
  • Views:

(Summary description)InnoModels Biotechnology has been actively exploring and promoting innovation in the field of biotechnology, and its Immunoco-culture Kill Model is undoubtedly an important technological achievement that the company is proud of. The application of this model in the field of immune research provides scientists with an unprecedented opportunity to gain an in-depth understanding of the complexity of the immune system and the potential for anti-tumor therapy

InnoModels Biotechnology: Immunoco-culture killing model features introduction

(Summary description)InnoModels Biotechnology has been actively exploring and promoting innovation in the field of biotechnology, and its Immunoco-culture Kill Model is undoubtedly an important technological achievement that the company is proud of. The application of this model in the field of immune research provides scientists with an unprecedented opportunity to gain an in-depth understanding of the complexity of the immune system and the potential for anti-tumor therapy

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-02-05 14:16
  • Views:
Information

InnoModels Biotechnology has been actively exploring and promoting innovation in the field of biotechnology, and its Immunoco-culture Kill Model is undoubtedly an important technological achievement that the company is proud of. The application of this model in the field of immune research provides scientists with an unprecedented opportunity to gain an in-depth understanding of the complexity of the immune system and the potential for anti-tumor therapy.
Highly reproducible in vivo immune microenvironment
InnoModels's immune co-culture killing model stands out for its high degree of reproduction of the in vivo immune microenvironment. By simulating the process of immune cell interactions in vivo, the model provides researchers with a more realistic and reliable experimental platform. This enables scientists to more accurately assess the effects of drug candidates in the immune system, providing a solid foundation for the development of novel therapeutic approaches.
Multi-dimensional immune cell evaluation
InnoModels's immune co-culture killing model not only restores the in vivo immune microenvironment, but also supports multi-dimensional immune cell assessment. Researchers can simultaneously examine the activity and interactions of multiple immune cell types, including T cells, B cells, macrophages, etc., to gain a more comprehensive understanding of the overall dynamics of the immune system. This provides critical data for a deeper understanding of the mechanisms of immunotherapy.

 


Application to anti-cancer therapy research
The immune co-culture killing model has great potential in anti-cancer therapy research. Through this model, researchers are able to assess the killing effect of immune cells on tumor cells, providing strong support for personalized anti-cancer therapy. This simulation of immune cell-tumor cell interactions can help discover new targets and drugs, and promote the innovative development of anticancer therapies.
Innovative data analysis and reporting tools
InnoModels Biotechnology focuses on providing users with innovative data analysis and reporting tools. The massive amount of data generated by the immune co-culture killing model can be interpreted by advanced analysis tools, providing researchers with a clear and intuitive presentation of experimental results. This innovative data analysis supports researchers to better understand the dynamics of the immune system, thus guiding drug development and optimization of therapeutic strategies.
Continuous Technology Upgrade and Service Support
InnoModels Biotechnology has been committed to the technological upgrading of immune co-culture killing models. By introducing new technologies and methods, the company ensures that its models remain at the forefront of science and technology. In addition, the company provides a full range of technical support and services to ensure that researchers are able to take full advantage of the immunoco-culture killing models for their scientific studies.
Summary
With its highly reproducible in vivo immune microenvironment, multi-dimensional immune cell assessment, application to anti-cancer therapeutic research, innovative data analysis and reporting tools, as well as continuous technological upgrades and service support, the Immunoculture Co-Culture Killing Model of InnoModels Biotechnology has become a leading tool in the field of immunology research. The features of this model not only provide researchers with an advanced experimental platform, but also inject new vitality into the research and development of the immunotherapy field.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司